Solventum Corp.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advance… Read more
Solventum Corp. (SOLV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.015x
Based on the latest financial reports, Solventum Corp. (SOLV) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.00 Million) by net assets ($4.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Solventum Corp. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Solventum Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Solventum Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solventum Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Covestro AG
PINK:CVVTF
|
0.048x |
|
MTU Aero Engines NA O.N.
LSE:0FC9
|
0.085x |
|
Universal Health Services Inc
NYSE:UHS
|
0.052x |
|
DS Smith PLC
PINK:DITHF
|
0.041x |
|
TMX Group Limited
PINK:TMXXF
|
0.026x |
|
New China Life Insurance Company Ltd
PINK:NWWCF
|
0.301x |
|
Intertek Group plc
PINK:IKTSF
|
0.123x |
|
AES Corp.
LSE:0H6G
|
0.123x |
Annual Cash Flow Conversion Efficiency for Solventum Corp. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Solventum Corp. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.96 Billion | $1.19 Billion | 0.400x | +143.96% |
| 2023-12-31 | $11.67 Billion | $1.92 Billion | 0.164x | +14.80% |
| 2022-12-31 | $11.74 Billion | $1.68 Billion | 0.143x | -21.69% |
| 2021-12-31 | $12.06 Billion | $2.20 Billion | 0.183x | -- |